Composition
- Active ingredients
- ICATIBANT ACETATE EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022150.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Firazyr
- Active substance
- icatibant acetate
- Route
- Subcutaneous
- Dosage form
- Injectable
- Applicant
- Takeda Pharms USA
- Status
- Prescription
- FDA approval
- 25 Aug 2011
- Application
- NDA022150-001